SiA Workshop with GSK - AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) Our 3HORIZONS consulting team lead a 2.5 day workshop with GSK - AREXVY on 12-14 March in collaboration with ESCP Business School. ✨ We're proud to serve as the dedicated Strategy Co-Pilot to businesses like GSK - AREXVY in rebooting their strategy for new markets!
🌍 Delivering SiA at GSK Arexvy From March 12-14, we partnered with GSK in Istanbul to reboot the strategy for their vaccine brand, AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted), across Turkey, Saudi Arabia, and Thailand. Together with Giovanni Scarso Borioli, Luca Dal Porto, and Alessandro Giraudo, we led a 2.5-day immersive workshop, in collaboration with ESCP Business School, to develop end-to-end strategic plans for these three key markets. Using the Strategy in Action methodology, we focused on shaping clear, actionable strategies to drive growth and align local teams in these diverse regions. 🔑 Key Highlights: ● 3 countries: Turkey, Saudi Arabia, Thailand ● Strategic reboot for Arexvy's vaccine brand ● A powerful 2.5-day workshop designed with SiA’s tailored approach in collaboration with ESCP Huge thanks to everyone involved: Rany Awadallah, Boudewijn Vismans, Sebastián Guerrero, Maria Eugenia Laucho-Contreras, Seda Yücecan, Barış Kamay, Gokcin Kara Dinler, Mahmoud El Raey, and Pattra Chaisri for their contributions. #SiA #StrategyActivation #Innovation
